376 related articles for article (PubMed ID: 16146349)
1. Bioequivalence studies for levothyroxine.
Bolton S
AAPS J; 2005 Mar; 7(1):E47-53. PubMed ID: 16146349
[TBL] [Abstract][Full Text] [Related]
2. Current methodology to assess bioequivalence of levothyroxine sodium products is inadequate.
Blakesley VA
AAPS J; 2005 Mar; 7(1):E42-6. PubMed ID: 16146348
[TBL] [Abstract][Full Text] [Related]
3. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
Green WL
AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
[TBL] [Abstract][Full Text] [Related]
5. United States Food and Drug Administration requirements for approval of generic drug products.
Meyer MC
J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
[TBL] [Abstract][Full Text] [Related]
7. Generic substitution: issues for problematic drugs.
Henderson JD; Esham RH
South Med J; 2001 Jan; 94(1):16-21. PubMed ID: 11213935
[TBL] [Abstract][Full Text] [Related]
8. Classification of torasemide based on the Biopharmaceutics Classification System and evaluation of the FDA biowaiver provision for generic products of CLASS I drugs.
Khan MZ; Rausl D; Radosević S; Filić D; Danilovski A; Dumić M; Knezević Z
J Pharm Pharmacol; 2006 Nov; 58(11):1475-82. PubMed ID: 17132210
[TBL] [Abstract][Full Text] [Related]
9. Levothyroxine dosage and the limitations of current bioequivalence standards.
Hennessey JV
Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):474-5. PubMed ID: 16957756
[No Abstract] [Full Text] [Related]
10. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the bioavailability and bioequivalence of generic medications.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
[TBL] [Abstract][Full Text] [Related]
12. [Preventable problems in thyroid hormone substitution therapy. The risks of brand change are unpredictable].
MMW Fortschr Med; 2010 Jun; 152(22):46-7. PubMed ID: 20590034
[No Abstract] [Full Text] [Related]
13. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
Quiroz J; Ting N; Wei GC; Burdick RK
Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence of thyroid preparations: the final word?
Gibaldi M
AAPS J; 2005; 7(1):E59-60. PubMed ID: 16493834
[No Abstract] [Full Text] [Related]
15. Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions.
Colucci P; D'Angelo P; Mautone G; Scarsi C; Ducharme MP
Ther Drug Monit; 2011 Jun; 33(3):355-61. PubMed ID: 21516059
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of generic preparations of levothyroxine.
Toft A
Clin Endocrinol (Oxf); 2009 Oct; 71(4):603; author reply 603-4. PubMed ID: 19508682
[No Abstract] [Full Text] [Related]
17. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable?
Blakesley V; Awni W; Locke C; Ludden T; Granneman GR; Braverman LE
Thyroid; 2004 Mar; 14(3):191-200. PubMed ID: 15072701
[TBL] [Abstract][Full Text] [Related]
18. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
[TBL] [Abstract][Full Text] [Related]
19. Current regulatory approaches of bioequivalence testing.
Karalis V; Macheras P
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):929-42. PubMed ID: 22681436
[TBL] [Abstract][Full Text] [Related]
20. What makes a generic medication generic?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2009 Dec; 47(12):17-20. PubMed ID: 20000278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
